Health Care
Summerset Group Holdings Limited (SNZ)
Summerset Group Holdings Limited operates retirement villages and aged care facilities, primarily across New Zealand and Australia. Its services include independent living, assisted living, and dementia care. SNZ focuses on senior housing solutions with a portfolio of over 5,000 homes.
Market Cap
A$2.4B
Shares on Issue
N/A
Price Chart
AI Analysis
Summerset Group Holdings has maintained a strong market position in the Australasian retirement and aged care sector, with recent performance reflecting steady occupancy rates and ongoing expansion plans. Key metrics highlight a diversified portfolio and strategic land holdings for future development, though market cap of A$2.4B positions it as a mid-cap with associated volatility.
Growth is anticipated through continued development of pipeline projects, particularly in high-demand areas of New Zealand and strategic Australian markets. SNZ's outlook is also influenced by regulatory environments and demographic trends favoring increased demand for senior living solutions.
Bull Case
- • Strong demographic demand driven by aging populations in NZ and AU.
- • Pipeline of development projects providing visible growth opportunities.
- • Diversified service offerings (independent to dementia care) enhancing revenue stability.
Bear Case
- • Regulatory changes in NZ/AU aged care could impact profitability.
- • Development risks (timing, cost overruns) on pipeline projects.
- • Interest rate rises increasing borrowing costs for residents and the company.
Recent Announcements
Notification of Director Nomination Dates
SPH Notice - Milford Asset Management Limited
4Q25 METRICS SALES OF OCCUPATION RIGHTS
🚨 Price SensitiveNew Zealand's Stat-Nation Z (SNZ) reports a strong end to the year with robust sales of occupation rights, signaling potential for growth in occupational therapy services. Investors are advised to monitor this sector closely due to increasing demand and regulatory changes that could
FAQs
What does SNZ do?
SNZ develops and operates retirement villages and aged care facilities in New Zealand and Australia.
Is SNZ a good investment?
SNZ offers growth potential via demographics and development pipeline, but investors must weigh this against regulatory and development risks, suitable for those seeking yield with moderate growth in the healthcare sector.
What drives SNZ's share price?
Key drivers include occupancy rates, development project timelines/costs, regulatory changes in aged care, and broader economic conditions affecting consumer confidence and borrowing costs.
Key Metrics
Related Stocks
Health Care
CSLCSL Ltd
A$181.24
-27.3% 1Y
CSL is a global biotechnology leader focused on plasma-derived therapies, vaccines, and specialty biologics.
Health Care
PNVPolynovo Ltd
A$0.99
-13.1% 1Y
Polynovo manufactures innovative wound care products used in burns, trauma, and reconstructive surgery.
Health Care
1ADAdalta Limited
A$0.01
-25.6% 1Y
Adalta Limited is a clinical-stage biotechnology company developing its proprietary i-body technology platform for treating a range of diseases. Based in Australia, its lead product candidate, AD-214, is being developed to treat Idiopathic Pulmonary Fibrosis (IPF) and other human fibrotic diseases.